Christopher B Ehrlich - Net Worth and Insider Trading
Christopher B Ehrlich Net Worth
The estimated net worth of Christopher B Ehrlich is at least $1,682 dollars as of 2024-06-18. Christopher B Ehrlich is the Director of eFFECTOR Therapeutics Inc and owns about 1,450 shares of eFFECTOR Therapeutics Inc (EFTR) stock worth over $1,682. Details can be seen in Christopher B Ehrlich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher B Ehrlich has not made any transactions after 2022-10-04 and currently still holds the listed stock(s).
Transaction Summary of Christopher B Ehrlich
Christopher B Ehrlich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher B Ehrlich owns 5 companies in total, including Paratek Pharmaceuticals Inc (PRTK) , Tesaro Inc (TSRO) , and Reshape Lifesciences Inc (RSLS) among others .
Click here to see the complete history of Christopher B Ehrlich’s form 4 insider trades.
Insider Ownership Summary of Christopher B Ehrlich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2009-01-30 | director |
| TSRO | Tesaro Inc | 2012-07-03 | 10 percent owner |
| RSLS | Reshape Lifesciences Inc | 2007-11-20 | 10 percent owner |
 | | 2022-10-04 | director & 10 percent owner & Chief Executive Officer |
| | 2021-10-05 | director & 10 percent owner & CEO and and Secretary |
Christopher B Ehrlich Latest Holdings Summary
Christopher B Ehrlich currently owns a total of 1 stock. Christopher B Ehrlich owns 1,450 shares of eFFECTOR Therapeutics Inc (EFTR) as of October 4, 2022, with a value of $1,682.
Latest Holdings of Christopher B Ehrlich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EFTR | eFFECTOR Therapeutics Inc | 2022-10-04 | 1,450 | 1.16 | 1,682 |
Holding Weightings of Christopher B Ehrlich
Christopher B Ehrlich Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher B Ehrlich has made a total of 6 transactions in eFFECTOR Therapeutics Inc (EFTR) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in eFFECTOR Therapeutics Inc is the acquisition of 14 shares on October 4, 2022, which cost Christopher B Ehrlich around $197.
Insider Trading History of Christopher B Ehrlich
- 1
Christopher B Ehrlich Trading Performance
GuruFocus tracks the stock performance after each of Christopher B Ehrlich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher B Ehrlich is -34.38%. GuruFocus also compares Christopher B Ehrlich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher B Ehrlich within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher B Ehrlich's insider trading performs compared to the benchmark.
Performance of Christopher B Ehrlich
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.43 | | | | | |
| Relative Return to S&P 500(%) | -7.04 | | | | | |
Christopher B Ehrlich Ownership Network
Christopher B Ehrlich Owned Company Details
What does Paratek Pharmaceuticals Inc do?
Who are the key executives at Paratek Pharmaceuticals Inc?
Christopher B Ehrlich is the director of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .
Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary
Over the past 18 months, Christopher B Ehrlich made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 72,456 shares made by Evan Loh , a net sale of 47,000 shares made by Michael Bigham , and a net sale of 41,533 shares made by William M. Haskel .
In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 213,881 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 788,500 shares were bought by its insiders, resulting in a net purchase of 574,619 shares.
Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Paratek Pharmaceuticals Inc Insider Transactions
Christopher B Ehrlich Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher B Ehrlich. You might contact Christopher B Ehrlich via mailing address: 499 Illinois Street, Suite 200, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
